Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/13938
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ueda J.-Y. | |
dc.contributor.author | Athikomkulchai S. | |
dc.contributor.author | Miyatake R. | |
dc.contributor.author | Saiki I. | |
dc.contributor.author | Esumi H. | |
dc.contributor.author | Awale S. | |
dc.date.accessioned | 2021-04-05T03:32:43Z | - |
dc.date.available | 2021-04-05T03:32:43Z | - |
dc.date.issued | 2013 | |
dc.identifier.issn | 11778881 | |
dc.identifier.other | 2-s2.0-84890483880 | |
dc.identifier.uri | https://ir.swu.ac.th/jspui/handle/123456789/13938 | - |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890483880&doi=10.2147%2fDDDT.S52168&partnerID=40&md5=ea6c9d63fff69e92ea9ba0f531c0a455 | |
dc.description.abstract | Human pancreatic tumors are known to be highly resistant to nutrient starvation, and this prolongs their survival in the hypovascular (austere) tumor microenvironment. Agents that retard this tolerance to nutrient starvation represent a novel antiausterity strategy in anticancer drug discovery. (+)-Grandiforacin (GF), isolated from Uvaria dac, has shown preferential toxicity to PANC-1 human pancreatic cancer cells under nutrient starvation, with a PC50 value of 14.5 μM. However, the underlying mechanism is not clear. In this study, GF was found to preferentially induce PANC-1 cell death in a nutrient-deprived medium via hyperactivation of autophagy, as evidenced by a dramatic upregulation of microtubule-associated protein 1 light chain 3. No change was observed in expression of the caspase-3 and Bcl-2 apoptosis marker proteins. GF was also found to strongly inhibit the activation of Akt, a key regulator of cancer cell survival and proliferation. Because pancreatic tumors are highly resistant to current therapies that induce apoptosis, the alternative cell death mechanism exhibited by GF provides a novel therapeutic insight into antiausterity drug candidates. © 2014 Ueda et al. | |
dc.subject | amino acid | |
dc.subject | antineoplastic agent | |
dc.subject | camptothecin | |
dc.subject | caspase 3 | |
dc.subject | deoxyglucose | |
dc.subject | fluorouracil | |
dc.subject | gemcitabine | |
dc.subject | glucose | |
dc.subject | Grandifloracin | |
dc.subject | mammalian target of rapamycin | |
dc.subject | paclitaxel | |
dc.subject | plant extract | |
dc.subject | podophyllotoxin | |
dc.subject | protein bcl 2 | |
dc.subject | unclassified drug | |
dc.subject | bridged compound | |
dc.subject | grandifloracin | |
dc.subject | protein kinase B | |
dc.subject | target of rapamycin kinase | |
dc.subject | AKT kinase assay | |
dc.subject | apoptosis | |
dc.subject | article | |
dc.subject | autophagy | |
dc.subject | cancer cell | |
dc.subject | cancer cell culture | |
dc.subject | cancer resistance | |
dc.subject | cell assay | |
dc.subject | cell death | |
dc.subject | cell proliferation | |
dc.subject | cell structure | |
dc.subject | cell survival | |
dc.subject | cell viability | |
dc.subject | comparative effectiveness | |
dc.subject | concentration response | |
dc.subject | controlled study | |
dc.subject | cytotoxicity | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | in vitro study | |
dc.subject | PANC 1 cell line | |
dc.subject | pancreas cancer | |
dc.subject | pancreas tumor | |
dc.subject | pharmacodynamics | |
dc.subject | protein expression | |
dc.subject | protein phosphorylation | |
dc.subject | starvation | |
dc.subject | upregulation | |
dc.subject | Uvaria | |
dc.subject | Western blotting | |
dc.subject | antagonists and inhibitors | |
dc.subject | dose response | |
dc.subject | drug effects | |
dc.subject | Pancreatic Neoplasms | |
dc.subject | pathology | |
dc.subject | tumor cell line | |
dc.subject | Apoptosis | |
dc.subject | Autophagy | |
dc.subject | Bridged Compounds | |
dc.subject | Cell Line, Tumor | |
dc.subject | Dose-Response Relationship, Drug | |
dc.subject | Humans | |
dc.subject | Pancreatic Neoplasms | |
dc.subject | Proto-Oncogene Proteins c-akt | |
dc.subject | TOR Serine-Threonine Kinases | |
dc.title | (+)-Grandiforacin, an antiausterity agent, induces autophagic PANC-1 pancreatic cancer cell death | |
dc.type | Article | |
dc.rights.holder | Scopus | |
dc.identifier.bibliograpycitation | Drug Design, Development and Therapy. Vol 8, (2013), p.39-47 | |
dc.identifier.doi | 10.2147/DDDT.S52168 | |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.